First Horizon Advisors, Inc. Abiomed Inc Transaction History

First Horizon Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$242.49 - $301.46 $242 - $301	1 Added 0.27%	366 $89,000
Q2 2022 Aug 02, 2022	BUY	$224.73 - $338.64 $78,880 - $118,862	351 Added 2507.14%	365 $90,000
Q1 2022 May 10, 2022	SELL	$277.25 - $366.29 $69,867 - $92,305	-252 Reduced 94.74%	14 $5,000
Q4 2021 Feb 09, 2022	SELL	$300.63 - $371.35 $1,202 - $1,485	-4 Reduced 1.48%	266 $95,000
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $12,407 - $15,048	40 Added 17.39%	270 $87,000
Q3 2021 Nov 09, 2021	SELL	$310.19 - $376.2 $7,754 - $9,405	-25 Reduced 9.8%	230 $74,000
Q1 2021 May 11, 2021	BUY	$285.92 - $355.13 $4,860 - $6,037	17 Added 7.14%	255 $81,000
Q4 2019 Jan 07, 2020	BUY	$159.31 - $223.54 $8,443 - $11,847	53 Added 28.65%	238 $40,000
Q2 2019 Aug 05, 2019	BUY	$250.96 - $284.94 $46,427 - $52,713	185 New	185 $0

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.